Finally, the p38 MAPK pathway activator, anisomycin, was used to explore the mechanism of ARAF in cancer cells.<h4>Results</h4>Intersecting genes related to bladder cancer were identified from the GeneCards and CTD databases, and ARAF was enriched in the p38MAPK pathway. This evidence concerns the gene ARAF and urinary bladder carcinoma.